ClinicalTrials.govpublic full text
Etanercept in Rheumatoid Arthritis and Vascular Inflammation
rheumatoid arthritis, vascular inflammation, anti-tumor necrosis factor alpha, 18-fluorodeoxyglucose positron emission tomography, high-sensitivity c- reactive protein, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 904174
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.